Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Icons
Spotlight Poster Icon
Spotlight Poster Icon
Spotlight Winner
Spotlight Winner

  • Friday, Aug 26th
    1:30 PM - 1:45 PM CEST
    Incretin-based Drugs and the Prevention of Chronic Obstructive Pulmonary Disease Exacerbations Among Patients with Type 2 Diabetes
    Location: Congress Hall D2
    Presenting Author: Sally Lu – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Co-Author: Richeek Pradhan, MD, MS – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Co-Author: Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada
    Co-Author: Oriana Hoi Yun Yu, MD, MSc – McGill University
    Co-Author: Pierre Ernst – McGill University
    Co-Author: Samy Suissa – McGill University
    Co-Author: Laurent Azoulay, PhD – McGill University, Montreal, Quebec, Canada
    Drug Effectiveness
  • Friday, Aug 26th
    1:30 PM - 1:45 PM CEST
    Does Treating Genital Herpes Infection During Pregnancy Reduce the Risk of Preterm Delivery? A Prospective Cohort Study of 89,000 Pregnant Women
    Location: C1M2
    Presenting Author: DeKun Li, MD, PhD – Kaiser Permanente
    Co-Author: Jeannette Ferber, n/a – Division of Research, Kaiser Foundation Research Institute
    Co-Author: Roxana Odouli – Division of Research, Kaiser Foundation Research Institute
    Co-Author: Piero Garzaro – The Permanente Medical Group
    Co-Author: Lyndsay Avalos – Kaiser Permanente Northern California Division of Research
    Co-Author: Charles Quesenberry, PhD – Kaiser Permanente Northern California Division of Research
    Drug Effectiveness
  • Friday, Aug 26th
    1:30 PM - 3:00 PM CEST
    Antidiabetics - Not Just About Diabetes
    Location: Congress Hall D2
    Moderator: Daniala L. Weir – Utrecht University
    Moderator: Dana Yael Teltsch, PhD – Takeda Pharmaceuticals International
    Drug Effectiveness
  • Friday, Aug 26th
    1:45 PM - 2:00 PM CEST
    Association Between Sodium Glucose Co-transporter 2 Inhibitors and Incident Glaucoma in Patients with Type 2 Diabetes: A Multi-institutional Cohort Study in Taiwan
    Location: Congress Hall D2
    Presenting Author: Shih-Chieh Shao, PhD candidate – Keelung Chang Gung Memorial Hospital
    Co-Author: Edward Lai, PhD – National Cheng Kung University
    Co-Author: Jia-Horung Hung – National Cheng Kung University
    Drug Effectiveness
  • Friday, Aug 26th
    2:00 PM - 2:15 PM CEST
    Heterogeneous Treatment Effect of Glucagon-like Peptide 1 Receptor Agonists on Asthma/COPD exacerbation: Machine-learning Analysis of Two Nationwide Cohorts
    Location: Congress Hall D2
    Presenting Author: Tiansheng Wang
    Co-Author: John Buse – Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill
    Co-Author: Corinne Keet – University of North Carolina at Chapel Hill
    Co-Author: Alexander Keil – University of North Carolina at Chapel Hill
    Co-Author: Richard Wyss, PhD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill
    Co-Author: Michele Jonsson Funk, PhD, FISPE – UNC Gillings School of Global Public Health
    Co-Author: Michael Kosorok – University of North Carolina at Chapel Hill
    Co-Author: Til Stürmer, MD, MPH, PhD, FISPE – UNC Gillings School of Global Public Health
    Drug Effectiveness
  • Friday, Aug 26th
    2:15 PM - 2:30 PM CEST
    Risk of Hepatic Events Associated with Sodium-glucose cotransporter-2 Inhibitors in Patients with Type 2 Diabetes: A Nationwide Cohort Study
    Location: Congress Hall D2
    Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University
    Co-Author: Han Eol Jeong, MPH, PhD – School of Pharmacy, Sungkyunkwan University
    Co-Author: Sohee Park – School of Pharmacy, SKKU
    Co-Author: Yoosoo Chang – Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea
    Co-Author: Dong Hyun Sinn – Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    Co-Author: Oriana Hoi Yun Yu, MD, MSc – McGill University
    Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University
    Drug Effectiveness
  • Friday, Aug 26th
    2:30 PM - 2:45 PM CEST
    Incretin-based Drugs and the Incidence of Prostate Cancer Among Patients with Type 2 Diabetes
    Location: Congress Hall D2
    Presenting Author: Sally Lu – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Co-Author: Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada
    Co-Author: Oriana Hoi Yun Yu, MD, MSc – McGill University
    Co-Author: Laurent Azoulay, PhD – McGill University, Montreal, Quebec, Canada
    Drug Effectiveness
  • Friday, Aug 26th
    2:45 PM - 3:00 PM CEST
    Association of Glucagon-like peptide-1 Receptor Agonists with Serious Liver Events: Scandinavian Cohort Study
    Location: Congress Hall D2
    Presenting Author: Arvid Engström – Karolinska Institutet
    Co-Author: Victor Wintzell – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm
    Co-Author: Mads Melbye – Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
    Co-Author: Henrik Svanström – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
    Co-Author: Björn Eliasson – Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
    Co-Author: Soffia Gudbjörnsdottir – Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
    Co-Author: Kristian Hveem – HUNT Research Center, Faculty of Medicine, NTNU—Norwegian University of Science and Technology, Levanger, Norway
    Co-Author: Christian Jonasson – HUNT Research Center, Faculty of Medicine, NTNU—Norwegian University of Science and Technology, Levanger, Norway
    Co-Author: Anders Hviid – Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
    Co-Author: Björn Pasternak – Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet
    Co-Author: Peter Ueda – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
    Drug Effectiveness
  • Saturday, Aug 27th
    8:15 AM - 8:30 AM CEST
    Evaluating the Long-term Effect of Allopurinol Use in Gout Using Marginal Structural Models: A Primary Care Electronic Health Records Study
    Location: C1M1
    Presenting Author: Trishna Rathod-Mistry – CSM, NDORMS, University of Oxford
    Co-Author: Edward Roddy, n/a – Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK
    Co-Author: Kelvin Jordan, n/a – Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK
    Co-Author: Christian Mallen, n/a – Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK
    Co-Author: Milisa Blagojevic-Bucknall, n/a – Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, UK
    Drug Effectiveness
  • Saturday, Aug 27th
    1:00 PM - 1:15 PM CEST
    Comparative Effectiveness of Direct Oral Anticoagulants versus Warfarin Among Nursing Home Residents with Atrial Fibrillation
    Location: C1M1
    Presenting Author: Hemalkumar B. Mehta, PhD – Bloomberg School of Public Health, Johns Hopkins University
    Co-Author: Huijun An, MS – Johns Hopkins Bloomberg School of Public Health
    Co-Author: Jodi Segal, FISPE – Johns Hopkins University
    Co-Author: James Goodwin – The University of Texas Medical Branch
    Co-Author: G. Caleb Alexander, MD – JHSPH Center for Drug Safety & Effectiveness
    Drug Effectiveness
  • Saturday, Aug 27th
    1:15 PM - 1:30 PM CEST
    The Effectiveness and Safety of Extended Anticoagulant Treatment in Patients with Venous Thromboembolism
    Location: C1M1
    Presenting Author: Nazleen F. Khan, SM – Brigham and Women's Hospital/Harvard Medical School
    Co-Author: Geetha Iyer, SM, MD, MBBS – Harvard T.H. Chan School of Public Health
    Co-Author: Helen Tesfaye – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Co-Author: Gregory Brill – Brigham and Women's Hospital/Harvard Medical School
    Co-Author: Katsiaryna Bykov, PharmD, ScD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Drug Effectiveness
  • Saturday, Aug 27th
    1:30 PM - 1:45 PM CEST
    Using Real-world Data to Assess Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation in the UK
    Location: C1M1
    Presenting Author: Liza R. Gibbs, MS – Aetion, Inc
    Co-Author: Priya Govil – Aetion, Inc
    Co-Author: Seamus Kent – National Institute for Health and Care Excellence
    Co-Author: Stephen Duffield – National Institute for Health and Care Excellence
    Co-Author: Shaun Rowark – National Institute for Health and Care Excellence
    Co-Author: Manuj Sharma – National Institute for Health and Care Excellence
    Co-Author: Ayad Ali, RPh, MSPharm, PhD, FACE – Aetion, Inc
    Co-Author: Amanda Patrick, MS – Aetion, Inc
    Co-Author: Ashley Jaksa – Aetion, Inc
    Co-Author: Pall Jonsson – National Institute for Health and Care Excellence
    Co-Author: Nicolle Gatto, PhD, FISPE – Aetion, Inc.
    Drug Effectiveness
  • Saturday, Aug 27th
    1:45 PM - 2:00 PM CEST
    Prophylactic Anticoagulation with Low Molecular Weight Heparin in COVID-19: Cohort Studies in Denmark and Sweden
    Location: C1M1
    Presenting Author: Lars Christian Lund
    Co-Author: Pontus Hedberg – Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Co-Author: Anne Helms Andreasen – Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
    Co-Author: Janne Petersen – Copenhagen Phase IV unit, Department of Clinical Pharmacology and Center for Clinical research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
    Co-Author: Tonny Petersen – Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark
    Co-Author: Anton PottegÃ¥rd, PhD, MSc – University of Southern Denmark
    Co-Author: Jacob Bodilsen – Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark
    Co-Author: Pontus Naucler – Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
    Co-Author: Jesper Hallas, MD, PhD, FISPE – University of Southern Denmark
    Co-Author: Espen Jimenez-Solem – Department of Clinical Pharmacology, Bispebjerg Hospital
    Drug Effectiveness
  • Saturday, Aug 27th
    2:00 PM - 2:15 PM CEST
    Risk of Ischemic Stroke Associated with DOAC Discontinuation on Patients with Non-valvular Atrial Fibrillation
    Location: C1M1
    Presenting Author: Tobias Álvaro Thomsen – Universidad Complutense de Madrid
    Co-Author: Jorge Mesa Guadalupe – Medical student
    Co-Author: Lucía Cea Soriano – Department of Public Health and Child Health. Faculty of Medicine. Universidad Complutense de Madrid
    Co-Author: Consuelo Huerta – Faculty of Medicine. Department of Public Health. Complutense University of Madrid
    Co-Author: Airam De Burgos – BIFAP, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain
    Drug Effectiveness
  • Saturday, Aug 27th
    2:15 PM - 2:30 PM CEST
    High-intensity versus Low- or Moderate-intensity Statin Treatment for Patients with Ischemic Stroke: Nationwide Cohort Study
    Location: C1M1
    Presenting Author: Frederikke Bach, BSc – Department of Clinical Epidemiology, Aarhus University
    Co-Author: Nils Skajaa
    Co-Author: Buket Öztürk Esen, MSc – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University & Aarhus University Hospital, Aarhus, Denmark
    Co-Author: Cecilia H. Fuglsang – Department of Clinical Epidemiology, Aarhus University
    Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
    Co-Author: Kasper Adelborg – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University & Aarhus University Hospital, Aarhus, Denmark
    Drug Effectiveness
  • Saturday, Aug 27th
    4:15 PM - 5:45 PM CEST
    Cloning, Censoring, and Weighting — Oh My! Applications of Target Trial Emulation for Evaluating Cancer Interventions When Study Eligibility, Intervention Initiation, and Start of Follow-up Are Not Aligned
    Location: Congress Hall D2
    Presenting Author: Jennifer L. Lund, PhD, FISPE – UNC Gillings School of Global Public Health
    Author: Xabier Garcia de Albeniz – RTI Health Solutions
    Author: Camille Maringe – London School of Hygiene and Tropical Medicine
    Author: Charles Gaber, PhD, MPH – University of Illinois-Chicago
    Author: Richard Wyss, PhD – Brigham and Women's Hospital, Harvard Medical School
    Author: Maribel Salas, DSc, MD, MSc, FISPE – Daiichi Sankyo
    Author: Armen A. Ghazarian – GlaxoSmithKline
    Drug Effectiveness
  • Saturday, Aug 27th
    5:30 PM - 5:45 PM CEST
    Comparative Effectiveness of Sotrovimab and Molnupiravir for Prevention of Severe COVID-19 Outcomes in Non-hospitalised Patients: An Observational Cohort Study Using the OpenSAFELY Platform
    Location: C1M2
    Presenting Author: John R. Tazare – London School of Hygiene and Tropical Medicine
    Co-Author: Bang Zheng – London School of Hygiene & Tropical Medicine
    Co-Author: Amelia Green – Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG
    Co-Author: Stephen Evans, MSc – Department of Medical Statistics, London School of Hygiene and Tropical Medicine
    Co-Author: Ian Douglas, PhD – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
    Co-Author: Brian MacKenna – University of Oxford
    Co-Author: Ben Goldacre – The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG
    Co-Author: Laurie Tomlinson, PhD – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
    Drug Effectiveness
  • Sunday, Aug 28th
    8:30 AM - 8:45 AM CEST
    HIV Pre-exposure Prophylaxis (PrEP) Effectiveness in the Real World: A Nested Case-control Study Among 46,706 Men at High Risk of HIV Infection in France
    Location: C1M0
    Presenting Author: Hugo JOURDAIN – EPI-Phare
    Co-Author: Sophie Billioti de Gage – French National Agency for Medicines and Health Products Safety
    Co-Author: David Desplas – EPI-PHARE
    Co-Author: Rosemary Dray-Spira – EPI-PHARE
    Drug Effectiveness
  • Sunday, Aug 28th
    8:30 AM - 8:45 AM CEST
    Sodium-glucose Co-transporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study
    Location: C1M1
    Presenting Author: Arvid Engström – Karolinska Institutet
    Co-Author: Victor Wintzell – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm
    Co-Author: Mads Melbye – Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
    Co-Author: Anders Hviid – Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
    Co-Author: Björn Eliasson – Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
    Co-Author: Soffia Gudbjörnsdottir – Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
    Co-Author: Kristian Hveem – HUNT Research Center, Faculty of Medicine, NTNU—Norwegian University of Science and Technology, Levanger, Norway
    Co-Author: Christian Jonasson – HUNT Research Center, Faculty of Medicine, NTNU—Norwegian University of Science and Technology, Levanger, Norway
    Co-Author: Henrik Svanström – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
    Co-Author: Björn Pasternak – Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet
    Co-Author: Peter Ueda – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
    Drug Effectiveness
  • Sunday, Aug 28th
    8:30 AM - 10:00 AM CEST
    Around the World With Real-World Evidence
    Location: C1M0
    Moderator: Meredith Y. Smith, FISPE, PhD, MPA – Evidera | PPD
    Moderator: Daniel Prieto-Alhambra, MD, MSc, PhD, FISPE – CSM, NDORMS, University of Oxford
    Drug Effectiveness
  • Sunday, Aug 28th
    8:30 AM - 10:00 AM CEST
    SGLT2s and Cardiovascular Endpoints
    Location: C1M1
    Moderator: Cynthia J. Girman, DrPH, FISPE – Patient Centered Outcomes Research Institute
    Moderator: Daniel Pilsgaard Henriksen – University of Southern Denmark
    Drug Effectiveness
  • Sunday, Aug 28th
    8:30 AM - 10:00 AM CEST
    The Effect of Remdesivir for The Treatment of COVID-19 on Mortality Among Hospitalized Patients
    Location: C1M0
    Presenting Author: Alexander S. Breskin, PhD – Target RWE
    Co-Author: Catherine Wiener – Target RWE
    Co-Author: M. Alan Brookhart, PhD – Duke University
    Drug Effectiveness
  • Sunday, Aug 28th
    8:45 AM - 9:00 AM CEST
    Use of Central Nervous System Drugs in Combination with Selective Serotonin Reuptake Treatment: A Bayesian Screening Study for Risk of Suicidal Behavior
    Location: C1M0
    Presenting Author: Zheng Chang – Karolinska Institutet
    Co-Author: Tyra Lagerberg – Karolinska Institutet
    Co-Author: Arvid Sjölander – Karolinska Institutet
    Co-Author: Robert Gibbons – University of Chicago
    Co-Author: Patrick Quinn – Indiana University
    Co-Author: Brian D'Onofrio – Indiana University
    Co-Author: Clara Hellner – Karolinska Institutet
    Co-Author: Paul Lichtenstein – Karolinska Institutet
    Co-Author: Seena Fazel – University of Oxford
    Drug Effectiveness
  • Sunday, Aug 28th
    8:45 AM - 9:00 AM CEST
    Cardiovascular Outcomes in Patients with Type 2 Diabetes Who Added Either GLP1 Receptor Agonists or DPP4 Inhibitors to SGLT2 Inhibitor Therapy
    Location: C1M1
    Presenting Author: Katsiaryna Bykov, PharmD, ScD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Seoyoung Kim, MD, DSc – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Chintan Dave, Pharm.D., PhD – Rutgers Center for Pharmacoepidemiology and Treatment Science
    Co-Author: Raisa Levin – Brigham and Women's Hospital
    Co-Author: Deborah Wexler, MD MSc – Massachusetts General Hospital
    Co-Author: Elisabetta Patorno – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Drug Effectiveness
  • Sunday, Aug 28th
    9:00 AM - 9:15 AM CEST
    Long-acting Injectable Antipsychotics and Risk of Treatment Failure in a Population-based Cohort
    Location: C1M0
    Presenting Author: Donica Janzen – The University of Manitoba
    Co-Author: James Bolton – Department of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba
    Co-Author: Christine Leong – College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba
    Co-Author: I fan Kuo – Drug Intelligence, Optimization, Outcomes and Strategy Branch, Pharmaceutical Services Division, B.C. Ministry of Health
    Co-Author: Silvia Alessi-Severini – College of Pharmacy, Rady Faculty of Health Sciences University of Manitoba, Winnipeg, Canada.
    Drug Effectiveness
  • Sunday, Aug 28th
    9:00 AM - 9:15 AM CEST
    Cardiovascular Effectiveness of Sodium—glucose Cotransporter 2 Inhibitors (SGLT-2i) and Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RA) in Routine Care of Frail People with Type 2 Diabetes
    Location: C1M1
    Presenting Author: Alexander Kutz – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
    Co-Author: Chandrasekar Gopalakrishnan – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Dae Hyun Kim – Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School
    Co-Author: Elisabetta Patorno – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Drug Effectiveness
  • Sunday, Aug 28th
    9:15 AM - 9:30 AM CEST
    Cardiovascular Effectiveness of SGLT2 Inhibitors: Head-to-head Comparisons
    Location: C1M1
    Presenting Author: Devin Abrahami, PhD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Elvira D'Andrea – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Deborah Wexler, MD MSc – Massachusetts General Hospital
    Co-Author: Brendan Everett – Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Co-Author: Seoyoung Kim, MD, DSc – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Elisabetta Patorno – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Drug Effectiveness
  • Sunday, Aug 28th
    9:30 AM - 9:45 AM CEST
    Association Between Very High PD-L1 Expression versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-small Cell Lung Cancer
    Location: C1M0
    Presenting Author: Mohsin Shah, MBBS, MSCE – IQVIA
    Co-Author: Melina Marmarelis, M.D. – Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
    Co-Author: Ronac Mamtani, M.D., M.S.C.E. – Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
    Co-Author: Rebecca Hubbard, Ph.D. – 1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania
    Co-Author: Sean Hennessy, Pharm. D., Ph.D. – Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania
    Drug Effectiveness
  • Sunday, Aug 28th
    9:30 AM - 9:45 AM CEST
    Cardiovascular Effectiveness of Empagliflozin vs. Glucagon-like peptide-1 Receptor Agonists or Liraglutide in the EMPRISE Study
    Location: C1M1
    Presenting Author: Phyo T. Htoo – Brigham and Women's Hospital/Harvard Medical School
    Co-Author: Helen Tesfaye – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Deborah Wexler, MD MSc – Massachusetts General Hospital
    Co-Author: Mehdi Najafzadeh – Brigham and Women's Hospital
    Co-Author: Robert Glynn, PhD, ScD – Harvard Medical School, Brigham and Women's Hospital
    Co-Author: Anouk Deruaz-Luyet – Boehringer Ingelheim International GmbH
    Co-Author: Soulmaz Farsani – Brigham and Women's Hospital
    Co-Author: Lisette Koeneman – Lilly Deutschland
    Co-Author: Sebastian Schneeweiss, ScD, MD, FISPE – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Elisabetta Patorno – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Drug Effectiveness
  • Sunday, Aug 28th
    9:45 AM - 10:00 AM CEST
    Does Hydroxychloroquine Prevent Cardiovascular Events in Systemic Lupus Erythematosus Patients?
    Location: C1M0
    Presenting Author: Lamiae Grimaldi, PharmD, PhD – Paris Saclay
    Co-Author: Tom Duchemin, PhD – Re-Meds France
    Co-Author: Philippe Attias, MD, MBA – Re-Meds France
    Co-Author: Yann Hamon – Re-Meds France
    Co-Author: Jacques Benichou – CHU Rouen, Department of Biostatistics and Clinical Research, F-76000 Rouen France
    Co-Author: Yola Moride, FISPE – Faculty of Pharmacy, Université de Montréal
    Co-Author: Lucien Abenhaim, MD, PhD – London School of Hygiene & Tropical Medicine
    Drug Effectiveness
  • Sunday, Aug 28th
    9:45 AM - 10:00 AM CEST
    Using Iterative Causal Forest to Identify Heterogeneous Treatment Effects: Sodium-glucose Cotransporter-2 inhibitors versus Glucagon-like Peptide-1 Receptor Agonists on Hospitalization for Heart Failure
    Location: C1M1
    Presenting Author: Tiansheng Wang
    Co-Author: Alexander Keil – University of North Carolina at Chapel Hill
    Co-Author: Siyeon Kim – University of North Carolina at Chapel Hill
    Co-Author: Richard Wyss, PhD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Phyo T. Htoo – Brigham and Women's Hospital/Harvard Medical School
    Co-Author: Michele Jonsson Funk, PhD, FISPE – UNC Gillings School of Global Public Health
    Co-Author: John Buse – Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill
    Co-Author: Michael Kosorok – University of North Carolina at Chapel Hill
    Co-Author: Til Stürmer, MD, MPH, PhD, FISPE – UNC Gillings School of Global Public Health
    Drug Effectiveness
  • Sunday, Aug 28th
    1:30 PM - 1:45 PM CEST
    Concurrent Use of Prescription Opioids with Other Medications and Risk of Fall and Fracture in Rheumatoid Arthritis Patients
    Location: Congress Hall D2
    Presenting Author: Nazleen F. Khan, SM – Brigham and Women's Hospital/Harvard Medical School
    Co-Author: Katsiaryna Bykov, PharmD, ScD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Jeffrey Katz – Brigham and Women's Hospital/Harvard Medical School
    Co-Author: Robert Glynn, PhD, ScD – Harvard Medical School, Brigham and Women's Hospital
    Co-Author: Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Co-Author: Seoyoung Kim, MD, DSc – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Drug Effectiveness
  • Sunday, Aug 28th
    1:30 PM - 3:00 PM CEST
    Fractures and Osteoporosis Medication
    Location: Congress Hall D2
    Moderator: Mary Anthony, PhD – RTI Health Solutions
    Moderator: Macarius M. Donneyong, PhD – The Ohio State University
    Drug Effectiveness
  • Sunday, Aug 28th
    1:45 PM - 2:00 PM CEST
    Effectiveness of Osteoporosis Medications on the Risk of Fracture: A French Population-based Cohort Study
    Location: Congress Hall D2
    Presenting Author: Pauline Bosco-Levy – Bordeaux PharmacoEpi
    Co-Author: James O'Kelly – Amgen Ltd, UK
    Co-Author: Karine Briot – Université de paris, INSERM U1153, hôpital Cochin, rhumatologie, 75014, Paris
    Co-Author: Nadia Mehsen-Cetre – CHU Bordeaux-Tripode, Service de Rhumatologie, 33076 Bordeaux
    Co-Author: Alban Fabre – Aetion Inc., Barcelona, Spain
    Co-Author: Régis Lassalle – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Univ. Bordeaux, Bordeaux, France
    Co-Author: Abdelilah Abouelfath – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Univ. Bordeaux, Bordeaux, France
    Co-Author: Angela Grelaud – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Univ. Bordeaux, Bordeaux, France
    Co-Author: Patrick Blin, MD, MSc – Bordeaux PharmacoEpi
    Co-Author: Cécile Droz-Perroteau – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Univ. Bordeaux, Bordeaux, France
    Drug Effectiveness
  • Sunday, Aug 28th
    2:00 PM - 2:15 PM CEST
    A Translational Approach to Study Drug-Drug Interaction with Hormonal Contraceptives: From Pharmacoepidemiology to Mechanistic Modelling
    Location: Congress Hall D2
    Presenting Author: Amir Sarayani, PharmD, MPH, PhD – University of Florida Department of Pharmaceutical Outcomes and Policy
    Co-Author: Brian Cicali – University of Florida
    Co-Author: Stephan Schmidt, PhD – Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA
    Co-Author: Joshua Brown, PharmD, PhD – Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL USA
    Co-Author: Almut Winterstein, PhD, FISPE – University of Florida
    Drug Effectiveness
  • Sunday, Aug 28th
    2:15 PM - 2:30 PM CEST
    Comparison of Denosumab versus Bisphosphonates on Progression-free and Overall Survival in Newly Diagnosed Multiple Myeloma: A New User, Active Comparator Analysis of Real-World Data
    Location: Congress Hall D2
    Presenting Author: Jenny Guadamuz – Jenny Guadamuz
    Co-Author: Mustafa S. Ascha – Flatiron Health, Inc
    Co-Author: Ghulam Rehman Mohyuddin – University of Utah School of Medicine
    Co-Author: Brian C.-H. Chiu – The University of Chicago
    Co-Author: Pritesh R. Patel – University of Illinois at Chicago
    Co-Author: Karen Sweiss – University of Illinois at Chicago
    Co-Author: Rebecca Rohrer, MPH – Flatiron Health
    Co-Author: Amy Pierre – Flatiron Health
    Co-Author: Erlene Seymour – Flatiron Health
    Co-Author: Douglas Sborov, MD, MS – Huntsman Cancer Institute at the University of Utah
    Co-Author: Gregory S. Calip, PharmD, MPH, PhD – Flatiron Health
    Drug Effectiveness
  • Sunday, Aug 28th
    2:45 PM - 3:00 PM CEST
    Treatment Heterogeneity in Comparative Effectiveness of Teriparatide vs. Bisphosphonates: Multi-database Cohort Study
    Location: Congress Hall D2
    Presenting Author: Alexandros Rekkas, MSc – Erasmus University Medical Center
    Co-Author: Annika Joedicke – University of Oxford
    Co-Author: David van Klaveren – Erasmus University Medical Center
    Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD, FISPE – CSM, NDORMS, University of Oxford
    Co-Author: Peter Rijnbeek – Erasmus University Medical Center, Rotterdam, The Netherlands
    Drug Effectiveness